DUBLIN--(BUSINESS WIRE)--The "Global Left Ventricular Assist Device Market - by Product, Type of Indication, Application, Region - Market Size, Demand Forecasts, Company Profiles, Industry Trends and ...

Medicare beneficiaries with heart failure who are Black or female were less likely to receive a left ventricular assist device (LVAD) implantation compared with White and male beneficiaries. Between ...

Nat Clin Pract Cardiovasc Med. 2006;3(7):346-347. Since the first widespread clinical application of left ventricular assist devices (LVADs) for patients with end-stage heart failure in the late 1980s ...

New concepts in device therapy for advanced heart failure presented in early reports ...

Fineheart SA will soon begin a first-in-human study of Flowmaker, its fully implantable left ventricular assist device, in France, after receiving authorization from the French National Agency for the ...

The Incor ® left-ventricular assist device (LVAD) (Berlin Heart AG, Germany) offers effective ventricular support without device-related infection or perioperative bleeding complications, a pilot ...

Please provide your email address to receive an email when new articles are posted on . Medtronic announced it has received a breakthrough device designation from the FDA for its fully implantable ...

Outcomes and expenses were similar with transplant and elective LVAD, but urgent LVAD after ECMO fared much worse.

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. The HeartMate II Left Ventricular ...

Patients who developed late right heart failure (RHF) after left ventricular assist device (LVAD) surgery suffered more major adverse events and had worse survival, researchers found. At 1 month ...

NEW YORK, March 10, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that U.S. FDA supports ...